Oncology

Since patients with Barrett's esophagus seem to progress to cancerous stages faster than others, health care professionals might perceive that controlling acid reflux would prevent the transition.

Opdivo was originally approved for patients with unresectable or metastatic melanoma who no longer respond to other drugs.

Better chemotherapy drugs lead to increased usage prior to breast operations over last 5 years.

Expanded use would include treatment of patients with advanced squamous non-small cell lung cancer who received prior therapy.

Compound can monitor biochemical processes involved with protein kinases.

Many physicians still use technique that fails to detect deep tissue lesions near the chest wall.

Study reveals optimistic findings for patients without other options for targeted cancer therapy.

Men who had testicular cancer also more likely to develop higher risk prostate cancers.

Study finds fewer women would support less frequent screening if they were found to be at lower risk.

Next generation chemotherapy may offer effective earlier treatment for disease.

Study finds shared decision making and accommodation of patient preferences improves quality.

Delivery system kills chemotherapy-resistant cancer stem cells and prevents secondary tumor formation.

Writer and neurologist Oliver Sacks confirms he has terminal cancer of the liver.

Experimental device offers non-invasive method to diagnose disease.

Activation of protein causes cells to change shape and become motile.

Enzyme associated with metabolic programming may lead to new treatments.

Company again selected as limited distribution pharmacy provider.

Study examines how side effects from commonly used antibiotics effect mitochondria of cancer cells.

Lenvima-treated patients experienced a median of 18.3 progression-free months.

Diabetics who took metformin saw a decreased chance of developing adenocarcinoma.

Annual rate of primary tumor removal has decreased since 1988.

Cells found to hijack vitamin D receptors to repair damage caused by therapy.

In 2014, the FDA approved notable new therapies for the treatment of cancer, bleeding disorders, inflammatory conditions, cystic fibrosis, pulmonary fibrosis, HIV, hepatitis C, multiple sclerosis, angioedema, and other conditions.

Trend reflects growing tobacco epidemic among women.

Genomic sequencing reveals effect of hepatitis on genetic mutations in tumors.

A recent study has identified how chronic hepatitis infection can pave the way to liver cancer.

Phase 3 trial for polycythemia vera drug significantly improved hematocrit control without the need for phlebotomy.

Progression-free survival improved from treatment during phase 3 trial.